Catapres recall: Failed Dissolution
Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT…
Why was Catapres recalled?
An extraneous peak was observed for dissolution testing.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 761544, 859015, EXP Jan 2021, 861346, 956626, EXP Jan 2022
- Product
- Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT…
- Recalling firm
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Quantity
- 13,270 bottles/100 tablets each
- Distribution
- Distributed Nationwide in the USA and Puerto Rico
- Recall date
- November 4, 2020
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)